Skip to main content

Research Repository

Advanced Search

Outputs (410)

The risk of keratinocyte carcinoma (KC) in psoriasis patients receiving biologic therapy compared with conventional systemic therapy: Results from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2018)
Presentation / Conference
Mason, K. J. (2018, August). The risk of keratinocyte carcinoma (KC) in psoriasis patients receiving biologic therapy compared with conventional systemic therapy: Results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). Poster presented at 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Prague Congress Centre, Prague, Czech Republic

Background: Whether psoriasis patients exposed to biologic therapies have an elevated risk of KC (basal cell carcinoma [BCC] or cutaneous squamous cell carcinoma [cSCC]) remains uncertain. Objectives: To determine whether such patients were at hig... Read More about The risk of keratinocyte carcinoma (KC) in psoriasis patients receiving biologic therapy compared with conventional systemic therapy: Results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

ADVERSE HEALTH RISKS IN ADOLESCENTS WITH BACK PAIN (2018)
Presentation / Conference
Williams, C., Kamper, S., Michaleff, Z., Campbell, P., Wiggers, J., Hodder, R., & Dunn, K. (2018, August). ADVERSE HEALTH RISKS IN ADOLESCENTS WITH BACK PAIN. Poster presented at 15th International Congress of Behavioral Medicine

Background Adverse health risk indicators such as substance use and psychological distress are public health priorities for adolescents. They are drivers of long term adverse health and social outcomes. For this reason they are common targets of publ... Read More about ADVERSE HEALTH RISKS IN ADOLESCENTS WITH BACK PAIN.

Identification of synovial fluid proteins that are associated with early osteoarthritis treatment failure: the search for novel markers leads us back to matrix metalloproteinases (MMPs) (2018)
Presentation / Conference
Hulme, C., Wilson, E., Fuller, H., Roberts, S., Richardson, J., Gallacher, P., …Wright, K. (2018, July). Identification of synovial fluid proteins that are associated with early osteoarthritis treatment failure: the search for novel markers leads us back to matrix metalloproteinases (MMPs). Poster presented at Matrix Biology Europe – July 2018 Meeting Celebrating 50 years of Federation of European Connective Tissue Societies Meetings, Manchester, United Kingdom

Introduction: Autologous chondrocyte implantation (ACI) is a cell therapy used to treat cartilage defects and early osteoarthritis. During initial surgery (Stage I), healthy cartilage is harvested from the joint. Chondrocytes are isolated and culture... Read More about Identification of synovial fluid proteins that are associated with early osteoarthritis treatment failure: the search for novel markers leads us back to matrix metalloproteinases (MMPs).

Targeting isocitrate lyase for the treatments of tuberculosis (2018)
Presentation / Conference
Bhusal, R., Patel, K., Kwai, B., Bashiri, G., Reynisson, J., & Sperry, J. (2018, July). Targeting isocitrate lyase for the treatments of tuberculosis. Poster presented at 43rd FEBS Congress, Biochemistry Forever, Prague, Czech

Supplement: 43rd FEBS Congress, Biochemistry Forever, Prague, Czech Republic, July 7‐12, 2018

Gestational diabetes mellitus: are mothers being followed-up? A retrospective study (2018)
Presentation / Conference
Ward, R., Hanna, F. W., Shelley-Hitchen, A., Hodgson, E., Heald, A., Fryer, A. A., & Duff, C. J. (2018, June). Gestational diabetes mellitus: are mothers being followed-up? A retrospective study

Background Women with gestational diabetes (GDM) have an elevated risk of developing type 2 diabetes (T2DM). NICE Guidance recommends women who develop GDM are screened 6 weeks post-partum and annually thereafter. Aim To evaluate conformity to gui... Read More about Gestational diabetes mellitus: are mothers being followed-up? A retrospective study.

THE RISK OF KC IN PSORIASIS PATIENTS RECEIVING BIOLOGICS COMPARED TO CONVENTIONAL SYSTEMIC THERAPIES (2018)
Presentation / Conference
Mason, K. (2018, June). THE RISK OF KC IN PSORIASIS PATIENTS RECEIVING BIOLOGICS COMPARED TO CONVENTIONAL SYSTEMIC THERAPIES. Poster presented at 5th World Psoriasis & Psoriatic Arthritis Conference, Stockholm, Sweden

Introduction: Whether psoriasis patients exposed to biologic therapies have an elevated risk of keratinocyte carcinoma (KC), including basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC) remains uncertain. Objective:The aim of t... Read More about THE RISK OF KC IN PSORIASIS PATIENTS RECEIVING BIOLOGICS COMPARED TO CONVENTIONAL SYSTEMIC THERAPIES.

OP0294-PARE Addressing key challenges of lay involvement in musculoskeletal research: co-applicants and trial steering committees (2018)
Presentation / Conference
Higginbottom, A., Blackburn, S., Taylor, R., Rhodes, C., Campbell, L., & Dziedzic, K. (2018, June). OP0294-PARE Addressing key challenges of lay involvement in musculoskeletal research: co-applicants and trial steering committees. Paper presented at Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018

Background Patient and Public Involvement (PPI) in research is a requirement of funding in the UK. It has shown to improve the relevance and quality of research. For over 10 years, a Research User Group (RUG) of over 100 patients with musculoskeletal... Read More about OP0294-PARE Addressing key challenges of lay involvement in musculoskeletal research: co-applicants and trial steering committees.

AB0212 Diagnostic delay for rheumatoid arthritis: a systematic review (2018)
Presentation / Conference
Hay, C., Prior, J., Scott, I., Raza, K., Hider, S., & Mallen, C. (2018, June). AB0212 Diagnostic delay for rheumatoid arthritis: a systematic review. Paper presented at Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, Netherlands

Background Rheumatoid arthritis (RA) is a common inflammatory condition, affecting 1% of the population and causing pain, stiffness and swelling, leading to significant disability and loss of function[.1 Delays in the diagnosis and treatment of RA ca... Read More about AB0212 Diagnostic delay for rheumatoid arthritis: a systematic review.